News release from Alzheimer’s Disease Data Initiative, ADDI
ADDI is pleased to announce its continued support of FBHI with a two-year grant on a project involving WW-FINGERS, including the adoption of the AD Workbench as a data sharing resource.
ADDI and FBHI are continuing to work together on a project involving WW-FINGERS, a global network of dementia-prevention trials. As part of this ongoing effort, ADDI and FBHI are implementing the AD Workbench, which will support data sharing among WW-FINGERS investigators and provides permissioned access to a global community of researchers. This is an exciting step forward for AD and related dementia research because these data are from diverse patient populations worldwide – thus, helping data demographics align with global demographics. Also, ADDI is working with FBHI to support the WW-FINGERS Scientific Helpdesk at FBHI, and harmonization efforts in the clinical trials within the WW-FINGERS network, which are key to expanding the data’s usability among researchers.
FINGERS Brain Health Institute (FBHI) is a nonprofit research foundation in Stockholm, Sweden. FBHI is dedicated to promoting healthy brain aging and preventing cognitive impairment and dementia through innovative multidomain clinical research and rapid translation of results into personalized interventions and clinical practice. The research activities are based on Professor Miia Kivipelto´s groundbreaking scientific results from the clinical FINGER-study.
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) is lifestyle-based and multi-dimensional. This study seeks to address the ability of nutrition, physical exercise, cognitive training, social activities and vascular/metabolic risk management to delay the onset of age-related cognitive impairment, including Alzheimer’s disease (AD) and related dementias. It has shown significant benefits in at-risk older adults in a large-scale, long-term randomized control trial. World-Wide FINGERS (WW-FINGERS) aims to adopt and expand the FINGER Study model to a rapidly increasing number of countries around the world, including low- and middle-income countries. This creates the first global network of multimodal dementia-prevention trials.
Alzheimer’s Disease Data Initiative (ADDI) is a US-based medical research organization that is dedicated to advancing scientific breakthroughs in the treatment of AD and related dementias. Through its AD Workbench, ADDI offers researchers access to a large and ever-growing number of important dementia-related datasets from across the globe. It also provides researchers with tools and other resources to assist in combining and analyzing data.
ADDI’s data sharing partnership with FBHI and WW-FINGERS is an encouraging step forward in discovering new treatments and cures for AD and related dementias. This is especially the case given that the WW-FINGERS network now includes studies from more than 40 nations – including a broad range of countries in East and South Asia, the Americas, and Europe. AD and related dementias research must include data from diverse populations and sharing data from these studies helps us better inform our global understanding of these diseases.
ADDI’s data sharing partnership with FBHI and WW-FINGERS is an encouraging step forward in discovering new treatments and cures for AD and related dementias. This is especially the case given that the WW-FINGERS network now includes studies from more than 40 nations – including a broad range of countries in East and South Asia, the Americas, and Europe. AD and related dementias research must include data from diverse populations and sharing data from these studies helps us better inform our global understanding of these diseases.
